20 results
8-K
EX-10.1
ALXO
Alx Oncology Holdings Inc
31 Oct 22
ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept
7:30am
has full power and authority to create a first lien on the Shares and no disability or contractual obligation exists that would prohibit Credit Party … of the incapacity, lack of authority or any disability or other defense of Borrower or Guarantor including any defense based on or arising out of the lack of validity
DEF 14A
jfwf1gn1vvqv9
29 Apr 21
Definitive proxy
4:01pm
10-K
3i84rypusgqlhcs7zjw
18 Mar 21
Annual report
4:25pm
424B4
4k5vr
11 Dec 20
Prospectus supplement with pricing info
12:00am
DRS
u70m u1pgzk5ljcl5x
24 Nov 20
Draft registration statement
12:00am
424B4
wp61k2mt
17 Jul 20
Prospectus supplement with pricing info
4:27pm
S-1
EX-10.15
ckwthyy
26 Jun 20
IPO registration
4:34pm
S-1
rmkchneuea7a6xz9vhyg
26 Jun 20
IPO registration
4:34pm
DRS/A
8jvi 225xbb
12 Jun 20
Draft registration statement (amended)
12:00am
DRS
i42efbaa yimje8rl7q
5 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next